Potential benefit of bosentan therapy in borderline or less severe pulmonary hypertension secondary to idiopathic pulmonary fibrosis—an interim analysis of results from a prospective, single-center, randomized, parallel-group study
Crossref DOI link: https://doi.org/10.1186/s12890-017-0523-2
Published Online: 2017-12-13
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tanaka, Yosuke
Hino, Mitsunori
Gemma, Akihiko